Patient characteristics
| Clinical characteristics . | No DVT/no PE (n = 20) . | Confirmed DVT/PE (n = 9) . |
|---|---|---|
| Age, y | 63.94 (24.87) | 67.33 (17.51) |
| % Female | 50 | 44.4 |
| Wells score (PE) | 0.50 (0.62) | 1.22 (0.44) |
| Wells score (DVT) | 0.44 (0.62) | 1.33 (1.12) |
| % on antiplatelet therapy (aspirin) | 15 | 33.3 |
| % on antiplatelet therapy (P2Y12 antagonist) | 0 | 0 |
| % with coronary artery disease | 15 | 33.3 |
| % with previous stroke | 10 | 22.2 |
| % on anticoagulation | 20 | 11.1 |
| Laboratory values | ||
| High-sensitivity troponin T, ng/ml | 0.067 (0.07) | 0.098 (0.19) |
| D-dimer, mg/ml | 2.15 (1.02) | 3.96 (2.89) |
| Leukocyte counts, G/l | 8.64 (3.64) | 7.61 (3.06) |
| Neutrophil counts, G/l | 6.77 (3.56) | 4.86 (1.77) |
| Platelet counts, G/l | 240 (72.56) | 233.38 (38.40) |
| C-reactive protein, mg/dl | 3.26 (5.32) | 1.27 (0.93) |
| Hemoglobin, g/dl | 12.71 (2.04) | 12.89 (1.20) |
| Clinical characteristics . | No DVT/no PE (n = 20) . | Confirmed DVT/PE (n = 9) . |
|---|---|---|
| Age, y | 63.94 (24.87) | 67.33 (17.51) |
| % Female | 50 | 44.4 |
| Wells score (PE) | 0.50 (0.62) | 1.22 (0.44) |
| Wells score (DVT) | 0.44 (0.62) | 1.33 (1.12) |
| % on antiplatelet therapy (aspirin) | 15 | 33.3 |
| % on antiplatelet therapy (P2Y12 antagonist) | 0 | 0 |
| % with coronary artery disease | 15 | 33.3 |
| % with previous stroke | 10 | 22.2 |
| % on anticoagulation | 20 | 11.1 |
| Laboratory values | ||
| High-sensitivity troponin T, ng/ml | 0.067 (0.07) | 0.098 (0.19) |
| D-dimer, mg/ml | 2.15 (1.02) | 3.96 (2.89) |
| Leukocyte counts, G/l | 8.64 (3.64) | 7.61 (3.06) |
| Neutrophil counts, G/l | 6.77 (3.56) | 4.86 (1.77) |
| Platelet counts, G/l | 240 (72.56) | 233.38 (38.40) |
| C-reactive protein, mg/dl | 3.26 (5.32) | 1.27 (0.93) |
| Hemoglobin, g/dl | 12.71 (2.04) | 12.89 (1.20) |
Data are given as mean (standard deviation) unless otherwise indicated.